STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
33 hedge funds and large institutions have $671K invested in Statera Biopharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$105K | |
| 2 | +$41.6K | |
| 3 | +$40.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$37K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$25.7K |
Top Sellers
| 1 | -$878K | |
| 2 | -$354K | |
| 3 | -$100K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$28K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$12K |